2. UroToday Home
  3. Journal
  4. Everyday Urologyâ„¢ – Oncology Insights
  5. Articles

AUA 2011 - Review of 1103 inflatable penile prosthetic surgeries performed in 2009 demonstrates almost complete variability for irrigation and antibiotic practice amongst eleven high-volume reconstructive surgeons - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Authors noted a 1% infection rate in first line IPP placement and a 3.8% in revisions.

AUA 2011 - Risk factors for upper urinary tract and urethral recurrences after radical cystectomy - Session Highlights

WASHINGTON, DC USA (UroToday.com) - It is unclear how often patients, after radical cystectomy, require upper tract imaging.

AUA 2011 - Sleep predicts the development of urologic symptoms in a longitudinal study - Session Highlights

WASHINGTON, DC USA (UroToday.com) - In men, LUTS is related to sleep <5 hours and restless sleep at least once per week.

AUA 2011 - State-of-the-art lecture: What is new in PSA based screening for prostate cancer - An update of the ERSPC study - Session Highlights

WASHINGTON, DC USA (UroToday.com) - A publication with 10 years follow-up is pending, but currently the data is embargoed.

AUA 2011 - SUFU at the AUA - Urinary incontinence: What we know, what we don't know, what we would like to know - Slide Presentation

WASHINGTON, DC USA (UroToday.com) - Presented by Alan J. Wein, MD, PhD (hon), Founders Professor and Chair of Urology, University of Pennsylvania, Penn Medicine/University of Pennsylvania Health System/Chief of Urology, Hospital of the University of Pennsylvania.

AUA 2011 - The VA/NCI/AHRQ CSP#407: Prostate Cancer Intervention Versus Observation Trial (PIVOT): Main results from a randomized trial comparing radical prostatectomy to watchful waiting in men with clinically localized prostate cancer - Session Highligh

WASHINGTON, DC USA (UroToday.com) - Dr. Timothy Wilt provided an update on the PIVOT trial; Prostate Cancer Intervention vs. Observation Trial.

AUA 2011 - Validation of a new lower urinary tract symptoms questionnaire - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Authors presented a 17 question, 5 point scale questionnaire that is validated and highly descriptive of voiding symptoms.

AUA 2011 - 5-alpha reductase inhibitors diminish the rate of progression in men with low risk prostate cancer on active surveillance - Session Highlights

WASHINGTON, DC USA (UroToday.com) - 5-alpha reductase inhibitors (5ARIs) are associated with a significantly lower rate of pathologic progression and abandonment of active surveillance, Dr. Antonio Finelli reported.

AUA 2011 - A Prospective analysis of prostatic artery embolization (PAE) as a primary treatment of benign prostatic hyperplasia: A pilot study - Session Highlights

WASHINGTON, DC USA (UroToday.com) - TURP is a suitable treatment for BPH, yet the relevant morbidity to the procedure and complications (an estimated 25 percent of benign prostatic hyperplasia (BPH) patients fail medication therapy or experience complication from TURP) are undesirable.

AUA 2011 - A Prospective analysis of prostatic artery embolization (PAE) as a primary treatment of benign prostatic hyperplasia: A pilot study - Slide Presentation

WASHINGTON, DC USA (UroToday.com) - Presented by Alberto A. Antunes, MD, Division of Urology, University of Sao Paulo Medical School, Sao Paulo, Brazil.

AUA 2011 - Age and aggressive prostate cancer in patients with low risk characteristics. Implications for conservative management - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Dr. Andrea Gallina reported that in low risk prostate cancer (CaP) patients subjected to radical prostatectomy (RP), higher rates of both pathological high grade and non-OC (NOC) disease should be expected in older men.

AUA 2011 - An operative performance rating system for urology residents - Session Highlights

WASHINGTON, DC USA (UroToday.com) - There is increasing interest by surgical educators to define the attainment of specific skills during the training program of surgical trainees.

AUA 2011 - Assessment of toxicity of stone-magnetizing microparticles in a murine model - Session Highlights

WASHINGTON, DC USA (UroToday.com) - The amalgamation of technology and health care was clearly evident during today’s podium session on urologic stone disease.

AUA 2011 - Back to baseline: Erectile function recovery (EFR) after radical prostatectomy (RP) from the patient’s perspective - Session Highlights

WASHINGTON, DC USA (UroToday.com) - The authors evaluated post-radical prostatectomy erectile function in patients with no prior history of PDE-5 use prior to surgery and no rehabilitation protocol post-RRPX.

AUA 2011 - Characterization of ureter, bladder, and bowel tissue injury after compression with robotic instruments - Session Highlights

WASHINGTON, DC USA (UroToday.com) - In the past decade, there has been an exponential increase in urological surgery utilizing the da Vinci robot platform.

AUA 2011 - Content and construct validation of robotic surgery curriculum using electromagnetic instrument tracker - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Another method of measuring surgeon performance is to measure economy of motion during execution of surgical tasks and skills.

AUA 2011 - Does the x-ray technologist or amount fluoroscopy time effect treatment success with extracorporeal shockwave lithotripsy? - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Extracorporeal shockwave lithotripsy (SWL) is considered the first line of treatment of small uncomplicated renal stones.

AUA 2011 - Effect of radical prostatectomy on penile shortening - Session Highlights

WASHINGTON, DC USA (UroToday.com) - A Swedish group reported that radical prostatectomy (RP) for prostate cancer results in patient self-assessed penile shortening.

AUA 2011 - Evaluation of a biodegradable ureteral stent in a Yorkshire pig model - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Dr. Ben Chew reported the results of a study examining the properties of a novel, biodegradable ureteral stent made from absorbable suture material (Uriprene, Oceanan Therapeutics, NJ).

AUA 2011 - Hospital discharge trends for benign prostatic hyperplasia, 1998-2007 - Session Highlights

WASHINGTON, DC USA (UroToday.com) - Researchers at the University of California San Diego reported a two-fold prevalence of BPH with and a three-fold incidence in acute renal failure.
Page 577 of 588